C07D 487 - Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups

Patents for C07D 487 - Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups (57,272)
11/2004
11/18/2004	US20040229879 CRF receptor antagonists and methods relating thereto
11/18/2004	US20040229877 Administering pyrrolotriazine carboxamide and benzamide compounds for therapy of p38 kinase-associated conditions
11/18/2004	US20040229870 Certain alkylene diamine-substituted heterocycles
11/18/2004	US20040229868 Heterocyclic compounds, methods for the preparation thereof, and uses thereof
11/18/2004	US20040229865 Cycloocta[b][1,4]diazepino[6,7,1-hi]indoles and derivatives
11/18/2004	US20040229864 An aromatic or heteroaromatic ring attached sulfone compound having a nitrogen containing hetero-mono, bi or tricyclic ring useful for treating sleep disorder and depression
11/18/2004	US20040229862 Imidazo-benzothiazoles
11/18/2004	US20040229848 For therapy of non-insulin dependent diabetes
11/18/2004	US20040229324 such as 5,6-dihydro-4H-pyrrolo(1,2-b)pyrazole-2-carboxylic acid; solvent extraction; for production of beta-lactamase inhibitors
11/18/2004	US20040228854 Novel chemical substance having morphogenetic and growth-accelerating activities
11/18/2004	US20040228807 Condensation aerosol for delivery of a drug selected from the group consisting of zaleplon, zolpidem and zopiclone
11/18/2004	DE19719831A1 Polymorphe beta-Form eines Isowurtzitan-Derivats und Verfahren zu ihrer Herstellung Beta-polymorphic form of a Isowurtzitan derivative and processes for their preparation
11/18/2004	DE10319159A1 Verfahren zur destillativen Gewinnung von hochreinem Triethylendiamin (TEDA) Process for the recovery of high purity distillation triethylene diamine (TEDA)
11/18/2004	CA2524274A1 4-bromo-5-(2-chloro-benzoylamino)-1h-pyrazole-3-carboxylic acid (1-(aminocarbonyl)eth-1-yl) amide derivatives and related compounds as bradykinin b1 receptor antagonists for the treatment of inflammatory diseases
11/18/2004	CA2524269A1 4- bromo - 5 - (2- chloro - benzoylamino) - 1h - pyrazole - 3 - carboxylic acid amide derivatives and related compounds as bradykinin b1 receptor antagonists for the treatment of inflammatory diseases
11/18/2004	CA2523072A1 Pyrrolo (1,2-b) pyridazine compounds and their use as crf-1 receptor antagonists
11/17/2004	EP1477490A1 Pyrrolopyrimidine derivative
11/17/2004	EP1477489A1 Pyrrolopyrimidine derivatives
11/17/2004	EP1477486A2 Imides as inhibitors of TNF alpha
11/17/2004	EP1477482A1 Novel phenylalanine derivative
11/17/2004	EP1477175A1 Fused pyridazine derivative compounds and drugs containing the compounds as the active ingredient
11/17/2004	EP1477169A1 Reactions of polymorphs of N-methyl-N-(3-(3-(2-thienylcarbonyl)-pyrazol-(1,5-alpha)-pyrimidin-7-yl)phenyl)acetamide
11/17/2004	EP1476507A1 Compounds, compositions and uses
11/17/2004	EP1476448A2 Azabicyclic compounds for the treatment of disease
11/17/2004	EP1476447A1 Cyclic compounds and their use as complex ligands
11/17/2004	EP1476446A1 Method for producing n-ethyl-n- 3-(3-cyanopyrazolo 1,5a]pyrimidine-7-yl)phenyl acetamide
11/17/2004	EP1476431A1 Tricyclic pyrazole derivatives for the treatment of inflammation
11/17/2004	EP1476151A1 1-arylsulfonyl-3-substitued indole and indoline derivates useful in the treatment of central nervous system disorders
11/17/2004	EP1412335A4 ENANTIOSELECTIVE TRANSFORMATION OF $g(a), $g(b)-UNSATURATED ALDEHYDES USING CHIRAL ORGANIC CATALYSTS
11/17/2004	EP1319006B1 Tetrahydrocarbazoles, a process for the preparation of those compounds, and the use thereof
11/17/2004	EP1296983B1 Novel process for the preparation of pyrazolopyrimidinones
11/17/2004	EP1222189B1 PROCESS FOR THE PREPARATION OF PYRIMIDO[5,4-g]PTERIDINE DERIVATIVES
11/17/2004	EP1214323B1 Indoloazepines as vasopressin receptor antagonists
11/17/2004	EP1210333B1 p-Tolyl-heterocycles as herbicides
11/17/2004	EP1087953B1 Nitrate salts of antihypertensive medicines
11/17/2004	EP1060175B1 Tryptase inhibitors
11/17/2004	EP0832092B1 Orally active adenosine kinase inhibitors
11/17/2004	CN1547583A 多环鸟嘌呤磷酸二酯酶v抑制剂 Polycyclic guanine phosphodiesterase inhibitor v
11/17/2004	CN1547472A Fused pyrimidines as d-alanyl-d-alanine ligase inhibitors
11/17/2004	CN1546492A Process for preparing 1.8-diazadicyclo [5,4,0] -7 undecene
11/17/2004	CN1546470A 6-phenylpyridyl-2-amine derivatives
11/16/2004	US6818763 Preparation of metal mesoporphyrin halide compounds
11/16/2004	US6818643 Neurotrophic bicyclic diamides
11/16/2004	US6818642 Benzylaminopyrimidines
11/16/2004	US6818641 Arthropodicidal carboxanilides
11/16/2004	US6818632 Protein tyrosine kinase and protein serin/threonine kinase inhibitory activity; anticancer agents; treating chemotherapy induced alopecia
11/16/2004	US6818262 Squarylium dyes
11/11/2004	WO2004097406A2 Nϵ AND/OR Nα DERIVATIZED, METAL AND ORGANIC PROTECTED L-HISTIDINE FOR COUPLING TO BIOMOLECULES FOR HIGHLY EFFICIENT LABELING WITH [M(OH2)3(CO)3]+ BY FAC COORDINATION
11/11/2004	WO2004096812A1 Fused pyrimidine derivative
11/11/2004	WO2004096811A1 Pde9 inhibitors for treating type 2 diabetes, metabokic syndrome, and cardiovascular disease
11/11/2004	WO2004096810A1 5,7-diaminopyrazolo`4,3-d!pyrimidines useful in the treatment of hypertension
11/11/2004	WO2004096809A1 1,2,3,4,5,6-hexahydroazepino[4,5-b]indoles containing arylsulfones at the 9-position
11/11/2004	WO2004096808A1 Triazine compounds and their use
11/11/2004	WO2004096807A2 Hiv integrase inhibitors
11/11/2004	WO2004096801A1 Cannabinoid receptor ligands and uses thereof
11/11/2004	WO2004096798A2 Derivatives of 2-acylamino-4-phenylthiazole, preparation method thereof and use of same as chemokine antagonists
11/11/2004	WO2004096236A2 Immunomodulator phosphonate conjugates
11/11/2004	WO2004096235A2 Anti-cancer phosphonate analogs
11/11/2004	WO2004096131A2 Inhibitors of akt activity
11/11/2004	WO2004087053A9 Dipeptidyl peptidase inhibitors
11/11/2004	WO2004078110A3 Fused imizadoles as transforming growth factor (tgf) inhibitors
11/11/2004	WO2004026844A9 Methods and compositions of novel triazine compounds
11/11/2004	WO2003097356A9 Camptothecin derivatives and polymeric conjugates thereof
11/11/2004	US20040225130 Imidazolyl derivatives as corticotropin releasing factor inhibitors
11/11/2004	US20040225001 Imidazolyl derivatives as corticotropin releasing factor inhibitors
11/11/2004	US20040224976 Azabicyclic compounds for the treatment of disease
11/11/2004	US20040224964 Corticotropin Releasing factor antagonist as drugs
11/11/2004	US20040224960 Pharmaceutical compositions and methods for their use
11/11/2004	US20040224958 Pyridopyrimidinone derivatives for treatment of neurodegenerative disease
11/11/2004	US20040224950 e.g., N-Cycloheptyl-N'(1-ethyl-pyrrolidin-2-ylmethyl)-6-(3-fluoro-4-methoxy-phenoxy)-[1,3,5]triazine-2,4-diamine; treating unwanted cellular proliferation, an inflammation mediated disease, or a hyperproliferative disease, or modulating a glycosidase enzyme
11/11/2004	US20040224944 Pyrazole compounds useful as protein kinase inhibitors
11/11/2004	US20040224875 Inhibitors of glutaminyl cyclase
11/11/2004	CA2523763A1 Fused pyrimidine derivative
11/11/2004	CA2522990A1 Hiv integrase inhibitors
11/11/2004	CA2522431A1 Inhibitors of akt activity
11/11/2004	CA2521158A1 Derivatives of 2-acylamino-4-phenylthiazole, preparation method thereof and application of same in therapeutics
11/11/2004	CA2520842A1 Cannabinoid receptor ligands and uses thereof
11/11/2004	CA2519840A1 Anti-cancer phosphonate analogs
11/10/2004	EP1475381A1 Aluminium and hexamethylenetetramine complex and the applications thereof
11/10/2004	EP1475094A1 Pyrazolo[4,3-D]pyrimidines, process for their preparation and methods of use
11/10/2004	EP1474426A2 Process for making carbapenem compounds
11/10/2004	EP1474424A1 Tricyclic 2-pyrimidone compounds useful as hiv reverse transcriptase inhibitors
11/10/2004	EP1474150A2 Use of 2-alkoxyphenyl-substituted imidazotriazinones
11/10/2004	EP1474147A1 Pyrimidine-based compounds useful as gsk-3 inhibitors
11/10/2004	EP1474139A2 11-beta-hydroxysteroid dehydrogenase 1 inhibitors useful for the treatment of diabetes, obesity and dyslipidemia
11/10/2004	EP1370560B1 Aminomethyl-pyrroloquinazoline compounds as thrombin receptor antagonists
11/10/2004	EP1343787B1 6-phenyl-pyrazolopyrimidines
11/10/2004	EP1161423B1 Thiazolyl urea derivatives and their utilization as antiviral agents
11/10/2004	CN1545516A Method for the production of 6-(4-chlorophenyl)-2,2-dimethyl-7-phenyl-2,3-dihydro-1h-pyrrolizin-5-ylacetic acid
11/10/2004	CN1544435A Metalloporphyrin synthesizing method
11/10/2004	CN1174985C Nonmetallic phthalocyanine and preparation and application thereof
11/10/2004	CN1174984C Carbamoyl tetrahydropyridine derivatives
11/09/2004	US6815458 Nervous system disorders
11/09/2004	US6815444 Anti-enterovirus compounds
11/09/2004	US6815438 Heteroaryl-diazabicycloalkanes
11/09/2004	US6815434 Administering otoprotectant glutathione peroxidase mimic (ebselen), xanthine oxidase inhibitor (allopurinol), and glutathione precursor (n-acetylcysteine)
11/09/2004	US6815214 Pharmaceutical uses and synthesis of diketopiperazines
11/09/2004	US6814955 Aerosol comprises particles of chlordiazepoxide, betahistine, clonidine, testosterone, conjugated estrogens, estrogen esters, estradiol, estradiol esters, ethinyl estradiol, ethinyl estradiol esters, or hyoscyamine.
11/09/2004	US6814954 Delivery of compounds for the treatment of Parkinsons through an inhalation route
11/04/2004	WO2004094432A1 Porphyrin compound containing biotinyl group and use thereof

1 ... 323 324 325 326 327 328 329 330 331 332 333 334 335 336 337 338 339 340 341 342 343 ... 573